FDA Proposes Amendments to Regulation of Medical Glove Testing
WASHINGTON -- The Food and Drug Administration (FDA) is proposing the amendment of its regulation on medical glove testing by implementing stricter acceptable quality levels (AQLs).
The amendment, which also would affect the sampling plans and test methods of medical glove testing, would improve the barrier quality of medical gloves in the domestic market, and would harmonize better with consensus standards.
Currently, In accordance with the regulation, the FDA examines the gloves for visual defects and water leaks, which are considered adulterated if they do not meet certain quality levels. The proposed update would reduce what the FDA considers an acceptable level of defects.
If the proposed amendment is accepted, the new AQLs would better harmonize with standards developed by the International Organization for Standardization and the American Society for Testing Materials.
The FDA requests all written or electronic comments to be submitted by June 30, 2003. For more information, see the proposed rule at http://www.fda.gov/OHRMS/DOCKETS/98fr/ 03-7601.html.
The Guardians of Animal Health: Who Are Veterinary Infection Preventionists?
March 21st 2025Veterinary infection control experts Leslie Kollmann, BS, AAS, CVT, CIC, Denise Waiting, LVT, and Leslie Landis, LVT, BS, discuss challenges, zoonotic disease risks, and the importance of education, collaboration, and resource development in animal care facilities.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.
Unmasking Long COVID: Dr Noah Greenspan on Recovery, Research Gaps, and the Future of Treatment
March 18th 2025Dr Noah Greenspan discusses the evolving understanding of long COVID, current treatment strategies, diagnostic challenges, and the critical need for research and awareness in post-viral syndromes.
